US68622P1093
US68622P1093
Oric Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 143.004.000 | 142.895.000 | 0.1% | |
| Operating Income | -143.004.000 | -142.895.000 | 0.1% |
| Pretax Income | -129.468.000 | -127.847.000 | 1.3% |
| Net Income Common Stockholders | -129.468.000 | -127.847.000 | 1.3% |
| -- | -- | -- | |
| -- | -- | -- |